Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
10000 participants
OBSERVATIONAL
2021-10-01
2022-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
2015
total number of poisoned patients in 2015, including their demographic data
Poison
standard of care and propre antidotes will be provided for each poisoned patients in addition to gastric lavage and activated charcoal administration when it is applicable
2016
total number of poisoned patients in 2016, including their demographic data
Poison
standard of care and propre antidotes will be provided for each poisoned patients in addition to gastric lavage and activated charcoal administration when it is applicable
2017
total number of poisoned patients in 2017, including their demographic data
Poison
standard of care and propre antidotes will be provided for each poisoned patients in addition to gastric lavage and activated charcoal administration when it is applicable
2018
total number of poisoned patients in 2018, including their demographic data
Poison
standard of care and propre antidotes will be provided for each poisoned patients in addition to gastric lavage and activated charcoal administration when it is applicable
2019
total number of poisoned patients in 2019, including their demographic data
Poison
standard of care and propre antidotes will be provided for each poisoned patients in addition to gastric lavage and activated charcoal administration when it is applicable
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Poison
standard of care and propre antidotes will be provided for each poisoned patients in addition to gastric lavage and activated charcoal administration when it is applicable
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
MTI University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dalia Kamal Zaafar Ali
Lecturer of clinical pharmacology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maha Wahdan
Role: STUDY_DIRECTOR
Lecturer of community and occupational medicine, faculty of medicine, Ain shams university
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
poison control centre Ain shams university hospitals
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Walaa Abdel Hamed, PhD
Role: primary
Dalia Zaafar, PhD
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ASU11032
Identifier Type: -
Identifier Source: org_study_id